Skip to main content
Publication date
2017 Oct
Authors
Brozek, JL Bousquet, J Agache, I Agarwal, A Bachert, C Bosnic-Anticevich, S Brignardello-Petersen, R Canonica, GW Casale, T Chavannes, NH de Sousa, JC Cruz, AA Cuello-Garcia, CA Demoly, P Dykewicz, M Etxeandia-Ikobaltzeta, I Florez, ID Fokkens, W Fonseca, J Hellings, PW Klimek, L Kowalski, S Kuna, P Laisaar, KT Larenas-Linnemann, DE Carlsen, KCL Manning, PJ Meltzer, E Mullol, J Muraro, A O'Hehir, R Ohta, K Panzner, P Papadopoulos, N Park, HS Passalacqua, G Pawankar, R Price, D Riva, JJ Roldan, Y Ryan, D Sadeghirad, B Samolinski, B Schmid-Grendelmeier, P Sheikh, A Togias, A Valero, A Valiulis, A Valovirta, E Ventresca, M Wallace, D Waserman, S Wickman, M Wiercioch, W Yepes-Nunez, JJ Zhang, L Zhang, Y Zidarn, M Zuberbier, T Schunemann, HJ
Author KI Usernames
Bachert, C|clabac
Pubmed ID
28602936
Journal
The Journal of allergy and clinical immunology
Doctype
Article
KI Connection
Låg
Mesh SV
Allergisk rinit Antiallergiska medel Astma Barn Djur Evidensbaserad praktik Histamin H1-blockerare Kliniskt beslutsfattande Livskvalitet Människa
Mesh EN
Anti-Allergic Agents Asthma Clinical Decision-Making Evidence-Based Practice Histamine H1 Antagonists Quality of Life Rhinitis, Allergic
First date
2017-10-22T10:54:22.857Z